Parsing the relationships among gut microbiome, neurotransmitter metabolome, glymphatic function, and cognition across healthy elderly, mild cognitive impairment, and probable Alzheimer's disease.
Oct 2026· Brain, behavior, and immunity· Vol 139, pp.
107067
· 0 citations· 78 references
Medicine
TL;DR
The gut microbiome, neurotransmitter metabolome, and a variety of glymphatic markers were measured in patients with clinically diagnosed probable AD and showed a wide range of associations, which may inform future preventive and therapeutic interventions by targeting the established pathways.
Abstract
Background
Evidence has suggested brain glymphatic dysfunction and gut microbial metabolic disturbance in Alzheimer's disease (AD), yet the relationships among gut microbiota, neurotransmitter metabolites, glymphatic function, and cognition across clinically defined groups of healthy elderly, mild cognitive impairment (MCI), and probable AD remain unclear.
Methods
Using metagenomic sequencing, targeted metabolomics, and multi-modal magnetic resonance imaging, we measured the gut microbiome, neurotransmitter metabolome, and a variety of glymphatic markers in 30 patients with clinically diagnosed probable AD, 75 individuals with MCI, and 59 healthy controls (HC).
Results
Although global microbial diversity showed no group difference, MCI and AD showed shared and unique species-level microbial alterations relative to HC. Despite the absence of overall metabolomic divergence, AD exhibited reduced levels of multiple neurotransmitter metabolites compared with MCI and HC. Prominent alterations in multiple glymphatic markers were present in AD rather than in MCI. Further integrated analyses revealed a wide range of associations among these multi-omics changes and established potential serial mediation pathways, manifesting as a pattern of gut microbiota → neurotransmitter metabolites → glymphatic function → cognition.
Conclusions
These findings could enrich our understanding of the biological mechanisms involved in cognitive impairment and clinically diagnosed probable AD, but also may inform future preventive and therapeutic interventions by targeting the established pathways.
Integrated multi-omic profiling reveals coordinated microbiome–metabolome dysregulation across the AD clinical spectrum, with taurine as a candidate microbial–metabolic node linking gut dysbiosis to cognitive performance.
Yi Feng, Yao Sha, Lu-Lu Xu et al.· Frontiers in Aging Neuroscie...· 0 citations
The gut-brain axis is implicated in Alzheimer's disease (AD), but fecal metabolomic changes across the healthy controls (HC)→subjective cognitive decline (SCD)→mild cognitive impairment (MCI)→AD clinical spectrum, especially at the SCD stage, remain poorly characterized. Without amyloid/tau confirmation, our groups...
Yi Feng, Rong-Qin Wu, Yu-Ming Chen et al.· Journal of Alzheimer's Disea...· 0 citations
Accumulating evidence suggests a link between the gut microbiota and metabolome and mild cognitive impairment (MCI); however, it remains largely unknown whether these parameters can aid MCI diagnosis and predict disease progression. We comprehensively characterized gut microbiota and metabolomic profiles in fecal sampl...
Bi-Rong Zhang, Richard Brown, A. Bayer et al.· MedComm· 0 citations
Background Gut microbial metabolism is increasingly implicated in Alzheimer’s disease (AD), mild cognitive impairment (MCI), preclinical amyloid accumulation, and cognitive aging. However, existing reviews often focus on microbial taxonomy rather than the metabolite mediators that connect the gut ecosystem with AD path...
Xiao-Teng He, Li-Li Zhang, Cai-Qiu Song et al.· Frontiers in Microbiology· 0 citations
Alzheimer’s disease (AD) is increasingly studied in relation to gut microbial mechanisms because microbial metabolism, mucosal barrier function, and peripheral immune activation may influence neuroinflammation and host metabolic stress. This review evaluates microbiome-linked evidence in AD with emphasis on studies tha...
The gut–brain axis has emerged as a central mechanistic framework linking dietary bioactives, microbial ecology, and neurodegenerative disease progression. Similar microbiome-related mechanisms have also been implicated in colorectal cancer, suggesting potential shared links between microbial dysbiosis, inflammation, a...
Yu-Jie Cheng, Mei-Ping Tao, Ke-Xin Qian et al.· Frontiers in Aging Neuroscie...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.